Beta Bionics, Inc. BBNX
We take great care to ensure that the data presented and summarized in this overview for Beta Bionics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BBNX
Top Purchases
Top Sells
About BBNX
Insider Transactions at BBNX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 13
2026
|
Danny L. Dearen |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+20.77%
|
-
|
|
Jan 13
2026
|
Adam Lezack |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+24.33%
|
-
|
|
Jan 13
2026
|
Christy Jones |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+20.77%
|
-
|
|
Jan 13
2026
|
Maria Palasis |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+24.33%
|
-
|
|
Jan 13
2026
|
Sean Carney |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+20.77%
|
-
|
|
Jan 13
2026
|
Gerard J Michel |
BUY
Grant, award, or other acquisition
|
Direct |
3,997
+19.46%
|
-
|
|
Jan 06
2026
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
2,200
-2.65%
|
$66,000
$30.1 P/Share
|
|
Jan 02
2026
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
7,800
-4.33%
|
$226,200
$29.88 P/Share
|
|
Jan 02
2026
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-31.94%
|
$580,000
$29.53 P/Share
|
|
Jan 02
2026
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+24.21%
|
$100,000
$5.1 P/Share
|
|
Dec 02
2025
|
Sean Saint President & CEO |
SELL
Open market or private sale
|
Direct |
3,278
-3.24%
|
$95,062
$29.34 P/Share
|
|
Dec 02
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,427
-3.24%
|
$41,383
$29.34 P/Share
|
|
Dec 02
2025
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
1,063
-1.16%
|
$30,827
$29.34 P/Share
|
|
Dec 01
2025
|
Maria Palasis |
SELL
Open market or private sale
|
Direct |
1,406
-7.4%
|
$40,774
$29.65 P/Share
|
|
Dec 01
2025
|
Adam Lezack |
SELL
Open market or private sale
|
Direct |
1,406
-7.4%
|
$40,774
$29.63 P/Share
|
|
Oct 31
2025
|
Maria Palasis |
SELL
Open market or private sale
|
Direct |
1,406
-6.32%
|
$37,962
$27.16 P/Share
|
|
Oct 31
2025
|
Adam Lezack |
SELL
Open market or private sale
|
Direct |
1,406
-6.27%
|
$37,962
$27.28 P/Share
|
|
Oct 03
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,982
-5.18%
|
$104,622
$21.9 P/Share
|
|
Oct 03
2025
|
Stephen Feider Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,982
+9.23%
|
$24,910
$5.1 P/Share
|
|
Oct 01
2025
|
Stephen Feider Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,018
-12.74%
|
$300,360
$20.92 P/Share
|
Last 12 Months Summary
Buy / Acquisition
4.41M
Shares
From
18
Insiders
| Grant, award, or other acquisition | 353K shares |
|---|---|
| Conversion of derivative security | 2.92M shares |
| Open market or private purchase | 1.03M shares |
| Exercise of in-the-money or at-the-money derivatives securities | 10.6K shares |
| Exercise of conversion of derivative security | 92.3K shares |
Sell / Disposition
132K
Shares
From
7
Insiders
| Open market or private sale | 132K shares |
|---|